Skip to main content
Clinical Trials/NCT00746928
NCT00746928UnknownNot Applicable

Cardiovascular Consequences of Intermittent Hypoxia in Healthy Subjects

University Hospital, Grenoble2 sites in 1 country12 target enrollmentStarted: September 1, 2005Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
12
Locations
2
Primary Endpoint
Blood Pressure

Study Overview

Brief Summary

The study is a prospective field evaluation to assess the effects of the chronic Intermittent Hypoxia exposure in 12 healthy humans.

Precisely, the study was designed to :

Set up a new model of Chronic Intermittent Hypoxia (CIH) applied to healthy human. This CIH is mimicking the CIH undergone by patients suffering from Sleep Apnea Syndrome.

Evaluate the cardiovascular effect of CIH. Neuronal and humoral sympathetic control, blood pressure control, vascular resistance.

Evaluate the Sleep quality, the ventilation under exposure and the long terms effect on ventilation control of CIH (central and peripheral chemoreflex).

Investigates the biological aspects of CIH exposure.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy subjects

Exclusion Criteria

  • Any history or significant medical condition

Outcomes

Primary Outcomes

Blood Pressure

Time Frame: Two Weeks

Secondary Outcomes

  • The ventilation under exposure and the long terms effect on ventilation control of CIH (central and peripheral chemoreflex)(two weeks)
  • Sleep quality(Two Weeks)
  • Neuronal and humoral sympathetic control and vascular resistance.(Two weeks)

Investigators

Sponsor
University Hospital, Grenoble
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials